Vorolanib Uses, Dosage, Side Effects and more
Vorolanib is under investigation in clinical trial NCT03904719 (CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)).
| Trade Name | Vorolanib |
| Generic | Vorolanib |
| Vorolanib Other Names | Vorolanib |
| Type | |
| Formula | C23H26FN5O3 |
| Weight | Average: 439.491 Monoisotopic: 439.20196788 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
